Costa L, Souza A, Scholl J, Figueiro F, Battastini A, Jaques J
Braz J Med Biol Res. 2021; 54(8):e10850.
PMID: 34037096
PMC: 8148981.
DOI: 10.1590/1414-431X2020e10850.
Mishra R, Agarwal M, Chansuria J
Indian J Otolaryngol Head Neck Surg. 2012; 52(4):360-3.
PMID: 23119724
PMC: 3451375.
DOI: 10.1007/BF02991478.
Bhattacharjee P, Sharma R
Mol Cell Biochem. 2009; 327(1-2):79-86.
PMID: 19229593
DOI: 10.1007/s11010-009-0045-1.
Mishra O, Ghosh J, Ali Z, Sen M, Prasad R
Pediatr Nephrol. 2005; 20(10):1426-9.
PMID: 16133068
DOI: 10.1007/s00467-005-1872-2.
Mishra O, Varshney K, Usha , Ali Z, Nath G, Pathak V
Indian J Pediatr. 2004; 71(4):301-5.
PMID: 15107509
DOI: 10.1007/BF02724093.
Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes.
Martin M, Centelles J, Huguet J, ECHEVARNE F, Colomer D, Vives-Corrons J
Clin Exp Immunol. 1993; 93(2):286-91.
PMID: 8348757
PMC: 1554837.
DOI: 10.1111/j.1365-2249.1993.tb07981.x.
The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
Smyth J, PAINE R, Jackman A, HARRAP K, Chassin M, Adamson R
Cancer Chemother Pharmacol. 1980; 5(2):93-101.
PMID: 6970630
DOI: 10.1007/BF00435411.
Localization and identity of adenosine deaminase-positive cells in tissues of the young rat and calf.
CHECHIK B, Baumal R, Sengupta S
Histochem J. 1983; 15(4):373-87.
PMID: 6190785
DOI: 10.1007/BF01002970.
Patterns of adenosine deaminase, ecto-5'-nucleotidase, poly(A)polymerase and surface light chain expression in chronic lymphocytic leukemias.
Trangas T, Courtis N, Gounaris A, Perez S, Kokkinopoulos D, Pangalis G
Blut. 1989; 58(4):187-93.
PMID: 2539869
DOI: 10.1007/BF00320771.
Deficiency of purine nucleoside phosphorylase activity in thymocytes from the immunodeficient diabetic BB rat.
Wu G, Marliss E
Clin Exp Immunol. 1991; 86(2):260-5.
PMID: 1834379
PMC: 1554134.
DOI: 10.1111/j.1365-2249.1991.tb05807.x.
Adenosine deaminase activity in leukaemia.
Smyth J, HARRAP K
Br J Cancer. 1975; 31(5):544-9.
PMID: 1057444
PMC: 2009433.
DOI: 10.1038/bjc.1975.95.
Adenosine deaminase activity in thymus and other human tissues.
Adams A, HARKNESS R
Clin Exp Immunol. 1976; 26(3):647-9.
PMID: 1009688
PMC: 1540957.
Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
SNYDER F, Mendelsohn J, Seegmiller J
J Clin Invest. 1976; 58(3):654-66.
PMID: 956393
PMC: 333224.
DOI: 10.1172/JCI108512.
In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin.
Smyth J, Young R, Young D
Cancer Chemother Pharmacol. 1978; 1(1):49-51.
PMID: 750104
DOI: 10.1007/BF00253146.
Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
Hall J, GYURE L, Peppard J, ORLANS E
Br J Cancer. 1979; 40(5):750-4.
PMID: 508578
PMC: 2010098.
DOI: 10.1038/bjc.1979.256.
In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.
Magnuson N, Perryman L
J Clin Invest. 1979; 64(1):89-101.
PMID: 447864
PMC: 372094.
DOI: 10.1172/JCI109468.
Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism.
Ambrogi F, Grassi B, Ronca-Testoni S, Ronca G
Clin Exp Immunol. 1977; 28(1):80-8.
PMID: 405169
PMC: 1540881.
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.
Smyth J, Poplack D, Holiman B, Leventhal B, Yarbro G
J Clin Invest. 1978; 62(3):710-2.
PMID: 308513
PMC: 371818.
DOI: 10.1172/JCI109179.
Role of adenosine deaminase in lymphocyte proliferation.
Hovi T, Smyth J, Allison A, Williams S
Clin Exp Immunol. 1976; 23(3):395-403.
PMID: 133008
PMC: 1538382.
